Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
DNLI on Nasdaq
E. Krognes - trading volume in the past year for Denali Therapeutics Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
782K |
$16.3M |
$20.81 |
Jan 7, 2025 |
Indirect |
|
|
| Common Stock |
25.8K |
$536K |
$20.81 |
Jan 7, 2025 |
Direct |
|
|
| Stock Option (right to buy) |
17.9K |
|
|
May 31, 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.